Showing results (261-270 of 316) with videos related to
Sort By:
Pageof 32
Internal Medicine (Tokyo, Japan)|April 11, 2022
Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case ReportsHideaki Oka, Yoshito Homma, Yuki Nishino, et al.Journal of Gastroenterology and Hepatology|July 25, 2007
Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and toleranceYu-Chun Lin, Chao-Long Chen, Toshiaki Nakano, et al.International Journal of Molecular Sciences|May 13, 2023
Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive BiomarkerToshiaki Nakano, Chao-Long Chen, I-Hsuan Chen, et al.BMC Nephrology|May 31, 2020
Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional studyYui Arita, Masaru Nakayama, Yuta Matsukuma, et al.Biomed Research International|February 5, 2015
A novel anti-histone H1 monoclonal antibody, SSV monoclonal antibody, improves lung injury and survival in a mouse model of lipopolysaccharide-induced sepsis-like syndromeToru Kusano, Kuei-Chen Chiang, Masafumi Inomata, et al.Transplant Immunology|February 20, 2007
Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressantsLi-Wen Hsu, Shigeru Goto, Toshiaki Nakano, et al.Nephrology (Carlton, Vic.)|January 29, 2026
A Case of Amyloid Arthritis With Increased Amyloid Deposition of Both β2-Microglobulin and Transthyretin Before Reinitiating Dialysis Long After Kidney TransplantationYuki Minami, Kenji Ueki, Miki Mito, et al.Biomedical Chromatography : BMC|July 3, 2007
Development of a two-step chromatography procedure that allows the purification of a high-purity anti-histone H1 monoclonal immunoglobulin M antibody with immunosuppressant activityYayoi Shimada, Takeshi Goto, Seiji Kawamoto, et al.Transplantation Research|April 27, 2013
Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipientsKing-Wah Chiu, Tsung-Hui Hu, Toshiaki Nakano, et al.Omics : a Journal of Integrative Biology|March 9, 2017
Hepatic miR-301a as a Liver Transplant Rejection Biomarker? And Its Role for Interleukin-6 Production in HepatocytesToshiaki Nakano, I-Hsuan Chen, Shigeru Goto, et al.Pageof 32